Uveal Malignant Melanoma: Epidemiologic Aspects

Clinical Ophthalmic Oncology

Volumn , Issue , 2007, Pages 198-204

  Singh, Arun D ^a   Bergman, Louise ^b   Seregard, Stefan ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882814780     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3167-3.50040-1     Document Type: Chapter

References (66)

1. Chang AE, Karnell LH, Menck HR The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998, 83:1664-1678.
2. Singh AD, Topham A Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology 2003, 110:956-961.
3. Strickland D, Lee JA Melanomas of eye: stability of rates. Am J Epidemiol 1981, 113:700-702.
4. Scotto J, Fraumeni JF, Lee JA Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 1976, 56:489-491.
5. Reis L, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1973-2000 2003, National Cancer Institute, Bethesda, MD, .
6. Barzilai DA, Koroukian SM, Neuhauser D, et al. The sensitivity of Medicare data for identifying incident cases of invasive melanoma (United States). Cancer Causes Control 2004, 15:179-184.
7. McLaughlin CC, Wu XC, Jemal A, et al. Incidence of noncutaneous melanomas in the US. Cancer 2005, 103:1000-1007.
8. Stang A, Jockel KH Trends in the incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control 2004, 15:95-96.
9. Singh AD, Bergman L, Seregard S Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am 2005, 18:75-84.
10. Vajdic CM, Kricker A, Giblin M, et al. Incidence of ocular melanoma in Australia from 1990 to 1998. Int J Cancer 2003, 105:117-122.
11. Michalova K, Clemett R, Dempster A, et al. Iris melanomas: are they more frequent in New Zealand?. Br J Ophthalmol 2001, 85:4-5.
12. Bergman L, Seregard S, Nilsson B, et al. Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci 2002, 43:2579-2583.
13. Egan KM, Seddon JM, Glynn RJ, et al. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988, 32:239-251.
14. Hu DN, Yu GP, McCormick SA, et al. Population-based incidence of uveal melanoma in various races and ethnic groups. Am J Ophthalmol 2005, 140:612-617.
15. Kaneko A Malignant ophthalmic tumors. Nippon Rinsho 1993, 51(Suppl):1013-1020.
16. Naumann G, Yanoff M, Zimmerman LE Histogenesis of malignant melanomas of the uvea. I. Histopathologic characteristics of nevi of the choroid and ciliary body. Arch Ophthalmol 1966, 76:784-796.
17. Yanoff M, Zimmerman LE Histogenesis of malignant melanomas of the uvea. II. Relationship of uveal nevi to malignant melanomas. Cancer 1967, 20:493-507.
18. Sahel JA, Pesavento R, Frederick AR, Albert DM Melanoma arising de novo over a 16-month period. Arch Ophthalmol 1988, 106:381-385.
19. Albert DM, Robinson NL, Fulton AB, et al. Epidemiological investigation of increased incidence of choroidal melanoma in a single population of chemical workers. Int Ophthalmol Clin 1980, 20:71-92.
20. Singh AD, Kalyani P, Topham B Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology 2005, 112:1784-1789.
21. Ponder BAJ Inherited cancer syndromes. Genes and cancer 1990, John Wiley and Sons, New York. D. Carney, K. Sikora (Eds.).
22. Singh AD, Damato B, Howard P, Harbour JW Uveal melanoma: genetic aspects. Ophthalmol Clin North Am 2005, 18:85-97.
23. Jay M, McCartney AC Familial malignant melanoma of the uvea and p53: a Victorian detective story. Surv Ophthalmol 1993, 37:457-462.
24. Singh AD, Donoso LA, Jackson L, et al. Familial uveal melanoma: absence of constitutional cytogenic abnormalities in 14 cases. Arch Ophthalmol 1996, 114:502-503.
25. Singh AD, Demirci H, Shields CL, et al. Concurrent choroidal melanoma in son and father. Am J Ophthalmol 2000, 130:679-680.
26. Hadden PW, Damato BE Simultaneous presentation of choroidal melanoma in mother and daughter. Br J Ophthalmol 2003, 87:793-794.
27. Barr CC, McLean IW, Zimmerman LE Uveal melanoma in children and adolescents. Arch Ophthalmol 1981, 99:2133-2136.
28. Singh AD, Shields CL, Shields JA, Sato T Uveal melanoma in young patients. Arch Ophthalmol 2000, 118:918-923.
29. Greer CH Congenital melanoma of the anterior uvea. Arch Ophthalmol 1966, 76:77-78.
30. Verdaguer J Prepuberal and puberal melanomas in ophthalmology. Am J Ophthalmol 1965, 60:1002-1011.
31. Singh AD, Shields JA, Eagle RC, et al. Iris melanoma in a ten-year-old boy with familial atypical mole-melanoma (FAM-M) syndrome. Ophthalm Genet 1994, 15:145-149.
32. Shammas HF, Watzke RC Bilateral choroidal melanomas. Case report and incidence. Arch Ophthalmol 1977, 95:617-623.
33. Singh AD, Shields CL, Shields JA, De Potter P Bilateral primary uveal melanoma. Bad luck or bad genes?. Ophthalmology 1996, 103:256-262.
34. Seregard S, Daunius C, Kock E, Popovic V Two cases of primary bilateral malignant melanoma of the choroid. Br J Ophthalmol 1988, 72:244-245.
35. Bergman L, Nilsson B, Ragnarsson-Olding B, Seregard S Uveal melanoma: A study on incidence of additional cancers in the Swedish population. Invest Ophthalmol Vis Sci 2005, 47:72-77.
36. Honavar SG, Shields CL, Singh AD, et al. Two discrete choroidal melanomas in an eye with ocular melanocytosis. Surv Ophthalmol 2002, 47:36-41.
37. Singh AD, Rundle PA, Slater DN, et al. Paraneoplastic melanocytic proliferation: uveal and cutaneous involvement. Arch Ophthalmology 2003, 121:1637-1640.
38. Gonder JR, Shields JA, Albert DM, et al. Uveal malignant melanoma associated with ocular and oculodermal melanocytosis. Ophthalmology 1982, 89:953-960.
39. Singh AD, De Potter P, Fijal BA, et al. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology 1998, 105:195-198.
40. Salopek TG The dilemma of the dysplastic nevus. Dermatol Clin 2002, 20:617-628.
41. Clark WH, Reimer RR, Greene M, et al. Origin of familial malignant melanomas from heritable melanocytic lesions: 'The B-K Mole syndrome'. Arch Dermatol 1978, 114:732-738.
42. NIH NIH Consensus conference. Diagnosis and treatment of early melanoma. JAMA 1992, 268:1314-1319.
43. Singh AD, Shields CL, Shields JA, et al. Uveal melanoma and familial atypical mole and melanoma (FAM-M) syndrome. Ophthalm Genet 1995, 16:53-61.
44. Bataille V, Sasieni P, Cuzick J, et al. Risk of ocular melanoma in relation to cutaneous and iris naevi. Int J Cancer 1995, 60:622-626.
45. van Hees CL, de Boer A, Jager MJ, et al. Are atypical nevi a risk factor for uveal melanoma? A case-control study. J Invest Dermatol 1994, 103:202-205.
46. Seregard S, af Trampe E, Mansson-Brahme E, et al. Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control study. Ophthalmology 1995, 102:1524-1529.
47. Greene MH, Sanders RJ, Chu FC, et al. The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome. Am J Ophthalmol 1983, 96:238-245.
48. de Snoo FA, Bergman W, Gruis NA Familial melanoma: a complex disorder leading to controversy on DNA testing. Fam Cancer 2003, 2:109-116.
49. Ohta M, Nagai H, Shimizu M, et al. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res 1994, 54:5269-5272.
50. Hurst EA, Harbour JW, Cornelius LA Ocular melanoma: a review and the relationship to cutaneous melanoma. Arch Dermatol 2003, 139:1067-1073.
51. Honavar SG, Singh AD, Shields CL, et al. Iris melanoma in a patient with neurofibromatosis. Surv Ophthalmol 2000, 45:231-236.
52. Foster WJ, Fuller CE, Perry A, Harbour JW Status of the NF1 tumor suppressor locus in uveal melanoma. Arch Ophthalmol 2003, 121:1311-1315.
53. Li FP, Fraumeni JF, Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988, 48:5358-5362.
54. Turner BJ, Siatkowski RM, Augsburger JJ, et al. Other cancers in uveal melanoma patients and their families. Am J Ophthalmol 1989, 107:601-608.
55. Lischko AM, Seddon JM, Gragoudas ES, et al. Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology 1989, 96:1716-1721.
56. Holly EA, Aston DA, Ahn DK, et al. No excess prior cancer in patients with uveal melanoma. Ophthalmology 1991, 98:608-611.
57. Diener-West M, Reynolds SM, Agugliaro DJ, et al. Second primary cancers after enrollment in the COMS trials for treatment of choroidal melanoma: COMS Report No. 25. Arch Ophthalmol 2005, 123:601-604.
58. Singh AD, Rennie IG, Seregard S, et al. Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol 2004, 49:419-428.
59. Shah CP, Weis E, Lajous M, et al. Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology 2005, 112:1599-1607.
60. Seddon JM, Gragoudas ES, Glynn RJ, et al. Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol 1990, 108:1274-1280.
61. Holly EA, Aston DA, Ahn DK, Smith AH Intraocular melanoma linked to occupations and chemical exposures. Epidemiology 1996, 7:55-61.
62. Vajdic CM, Kricker A, Giblin M, et al. Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer 2002, 101:175-182.
63. Ajani UA, Seddon JM, Hsieh CC, et al. Occupation and risk of uveal melanoma. An exploratory study. Cancer 1992, 70:2891-2900.
64. Guenel P, Laforest L, Cyr D, et al. Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case-control study in France. Cancer Causes Control 2001, 12:451-459.
65. Vidal JL, Bacin F, Albuisson E, et al. 'Melanoma 92.' An epidemiological study of uveal melanoma in France. J Fr Ophtalmol 1995, 18:520-528.
66. Tucker MA, Shields JA, Hartge P, et al. Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med 1985, 313:789-792.